analyst
AC
NASDAQ · ACTU
Actuate Therapeutics Inc
Healthcare · Biotechnology
$1.15
Down-$0.07 (-6.09%)
Updated Sep 11, 2026, 5:44 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 86.93M
- P/E ratio
- -3.32
- Dividend yield
- 0.00%
- 52-week range
- $0.90 – $8.49
- Volume
- 205K
- Avg. volume
- 71.29K
Price performance
ACTU price history
1M range · 20 trading sessions · Daily adjusted prices
ACTU closed at $1.15 after 20 trading sessions, up 17.94% for the selected period.
- Last close
- $1.15
- Period change
- +17.94%
- Period low
- $0.98
- Period high
- $1.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $1.25 | $1.28 | $1.13 | $1.15 | 205K |
| Sep 9, 2026 | $1.38 | $1.3999 | $1.26 | $1.26 | 124.42K |
| Sep 8, 2026 | $1.46 | $1.48 | $1.3301 | $1.37 | 210.02K |
| Sep 4, 2026 | $1.45 | $1.73 | $1.33 | $1.48 | 1.32M |
| Sep 3, 2026 | $1.39 | $1.46 | $1.26 | $1.37 | 474.04K |
| Sep 2, 2026 | $1.50 | $1.55 | $1.30 | $1.30 | 335.53K |
| Sep 1, 2026 | $1.49 | $1.58 | $1.4101 | $1.54 | 129.76K |
| Aug 31, 2026 | $1.64 | $1.65 | $1.46 | $1.52 | 274.74K |
| Aug 28, 2026 | $1.69 | $1.7799 | $1.6301 | $1.655 | 231.3K |
| Aug 27, 2026 | $1.77 | $1.7963 | $1.63 | $1.69 | 366.08K |
| Aug 26, 2026 | $1.73 | $1.97 | $1.57 | $1.78 | 3.3M |
| Aug 25, 2026 | $1.24 | $1.58 | $1.2001 | $1.58 | 589.19K |
| Aug 24, 2026 | $1.28 | $1.3095 | $1.1805 | $1.23 | 179.29K |
| Aug 21, 2026 | $1.22 | $1.3418 | $1.18 | $1.27 | 275.82K |
| Aug 20, 2026 | $1.06 | $1.34 | $1.0101 | $1.23 | 938.99K |
| Aug 19, 2026 | $1.04 | $1.10 | $1.00 | $1.06 | 156.64K |
| Aug 18, 2026 | $1.00 | $1.14 | $0.9889 | $1.05 | 327.91K |
| Aug 17, 2026 | $1.02 | $1.03 | $0.95 | $0.99 | 130.43K |
| Aug 14, 2026 | $0.966 | $1.03 | $0.90 | $1.01 | 109.73K |
| Aug 13, 2026 | $0.98 | $0.985 | $0.9423 | $0.9751 | 100.99K |
Latest ACTU news
The latest Smart Investors Daily articles mentioning ACTU.
Stock researchCompany · Financials
Loading stock research…